首页> 外文期刊>Surgery >Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival
【24h】

Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival

机译:腹腔镜切除胰腺中部和远端的外分泌癌可提高根治性切除率,延长术后生存期

获取原文
获取原文并翻译 | 示例
       

摘要

Background: The role of laparoscopic resection in patients with pancreatic cancer remains to be clarified, because previous reports have not clearly defined oncologic outcomes. The objective of the present study was to investigate this question with the rate of R0 resection and long-term survival as endpoints. Methods: This retrospective observational study included prospectively collected data from 40 patients operated laparoscopically with curative intent for exocrine pancreatic malignancies identified among 250 consecutive patients undergoing laparoscopic pancreatic operations since 1997. All 40 patients had histologically verified exocrine pancreatic carcinoma. Results: Ten patients (25%) with typical ductal adenocarcinoma of the pancreas were deemed nonresectable by laparoscopic staging. Laparoscopic distal pancreatectomy was performed in 29 patients; 8 resections were combined with resections of adjacent organs and 1 removal of a malignant intraductal papillary mucinous neoplasm what appeared to be ectopic pancreatic tissue. In 1 patient, the resection was completed by hand-assisted technique, and 1 procedure was converted to open resection. Postoperative morbidity was 23% (n = 7). The median hospital stay was 5 days (range, 1-30). The rate of R0 resections was 93%. Postoperative 3-year survivals rates were 36% for the entire cohort (n = 30) and 30% in typical ductal adenocarcinoma (n = 21). Conclusion: Laparoscopic distal pancreatectomy for exocrine pancreatic carcinoma is comparable with outcomes after open surgery and supports the concept that laparoscopic distal pancreatectomy is a safe, oncologic procedure.
机译:背景:腹腔镜切除术在胰腺癌患者中的作用尚待阐明,因为以前的报道尚未明确定义肿瘤学结局。本研究的目的是以R0切除率和长期生存率为终点来研究这个问题。方法:这项回顾性观察性研究包括前瞻性收集的数据,自1997年以来在250例接受腹腔镜胰腺手术的连续患者中确定了40例经腹腔镜手术治疗且具有治愈意图的外分泌胰腺恶性肿瘤。所有40例患者均经组织学证实为外分泌胰腺癌。结果:十例(25%)典型的胰腺导管腺癌患者经腹腔镜分期被认为不可切除。腹腔镜远端胰腺切除术29例。将8例切除术与相邻器官切除术相结合,并切除1例看似异位胰腺组织的恶性导管内乳头状粘液性肿瘤。 1例患者通过手工辅助技术完成了切除,并将1例手术转变为开放性切除。术后发病率为23%(n = 7)。中位住院天数为5天(范围1-30)。 R0切除率为93%。整个队列的术后3年生存率分别为36%(n = 30)和典型导管腺癌的30%(n = 21)。结论:腹腔镜远端胰腺切除术用于外分泌性胰腺癌的效果与开放手术后的结果相当,并支持腹腔镜远端胰腺切除术是一种安全的肿瘤学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号